Shirley R. Kuhlmann
Net Worth
Last updated:
What is Shirley R. Kuhlmann net worth?
The estimated net worth of Ms. Shirley R. Kuhlmann is at least $11,923,346 as of 3 Jun 2024. She owns shares worth $5,209,714 as insider, has earned $3,303,082 from insider trading and has received compensation worth at least $3,410,550 in Collegium Pharmaceutical, Inc..
What is the salary of Shirley R. Kuhlmann?
Ms. Shirley R. Kuhlmann salary is $682,110 per year as Executive Vice President, Gen. Counsel & Sec. in Collegium Pharmaceutical, Inc..
How old is Shirley R. Kuhlmann?
Ms. Shirley R. Kuhlmann is 41 years old, born in 1984.
What stocks does Shirley R. Kuhlmann currently own?
As insider, Ms. Shirley R. Kuhlmann owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Collegium Pharmaceutical, Inc. (COLL) | Executive Vice President, Gen. Counsel & Sec. | 139,409 | $37.37 | $5,209,714 |
What does Collegium Pharmaceutical, Inc. do?
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Shirley R. Kuhlmann insider trading
Collegium Pharmaceutical, Inc.
Ms. Shirley R. Kuhlmann has made 11 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently she sold 24,300 units of COLL stock worth $790,916 on 3 Jun 2024.
The largest trade she's ever made was exercising 38,589 units of COLL stock on 15 Sep 2022. As of 3 Jun 2024 she still owns at least 139,409 units of COLL stock.
Collegium Pharmaceutical key executives
Collegium Pharmaceutical, Inc. executives and other stock owners filed with the SEC:
- Dr. Richard Malamut (65) Executive Vice President & Chief Medical Officer
- Mr. Joseph J. Ciaffoni (54) Pres, Chief Executive Officer & Director
- Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph. (61) Co-Founder & Chairman
- Ms. Shirley R. Kuhlmann (41) Executive Vice President, Gen. Counsel & Sec.